INVITRO RELEASE PROFILE OF ESTRADIOL TRANSDERMAL THERAPEUTIC SYSTEMS

被引:18
作者
TYMES, NW
SHAH, VP
SKELLY, JP
机构
[1] US FDA,CTR DRUG EVALUAT & RES,ROCKVILLE,MD 20857
[2] BALTIMORE DIST LAB,BALTIMORE,MD 21201
关键词
D O I
10.1002/jps.2600790711
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The in vitro release profiles of two sizes of estradiol patches were determined by the paddle method, where the patch was held in position at the bottom of the dissolution vessel by sandwiching it between a watch glass and an aluminum wire mesh or Teflon screen, and also by the manufacturer's paddle‐over‐disk method. The estradiol content of test aliquots of the dissolution medium was determined by HPLC. The release profiles by both procedures were comparable and showed that ∼10% of the labeled drug was released in 4 days. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:601 / 602
页数:2
相关论文
共 8 条
[1]   INVITRO DISSOLUTION PROFILE OF TRANSDERMAL NITROGLYCERIN PATCHES USING PADDLE METHOD [J].
SHAH, VP ;
TYMES, NW ;
YAMAMOTO, LA ;
SKELLY, JP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 32 (2-3) :243-250
[2]   INVITRO RELEASE PROFILES OF CLONIDINE TRANSDERMAL THERAPEUTIC SYSTEMS AND SCOPOLAMINE TRANSDERMAL PATCHES [J].
SHAH, VP ;
TYMES, NW ;
SKELLY, JP .
PHARMACEUTICAL RESEARCH, 1989, 6 (04) :346-351
[3]   COMPARATIVE INVITRO RELEASE PROFILES OF MARKETED NITROGLYCERIN PATCHES BY DIFFERENT DISSOLUTION METHODS [J].
SHAH, VP ;
TYMES, NW ;
SKELLY, JP .
JOURNAL OF CONTROLLED RELEASE, 1988, 7 (01) :79-86
[4]   TESTING OF CONTROLLED-RELEASE TRANSDERMAL DOSAGE FORMS - PRODUCT DEVELOPMENT AND CLINICAL-TRIALS [J].
SHAW, JE ;
PREVO, ME ;
AMKRAUT, AA .
ARCHIVES OF DERMATOLOGY, 1987, 123 (11) :1548-1556
[5]  
1985, US PHARM S, V7, P2768
[6]  
1989, PHYSICIANS DESK REFE, P844
[7]  
1985, US PHARM, P1243
[8]  
1985, US PHARM S, V8, P3080